Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Endocare (ENDO) -- Ignore unavailable to you. Want to Upgrade?

To: Juster who wrote (47)	1/6/1999 4:11:00 PM
From: Street Walker	Read Replies (1) \| Respond to of 99

I bought today for at 2 1/32 for a short term hold. I'm looking for the news to come out in about 3 weeks. The medicare mtg went extremely well. Think of this: your representing Medicare in a meeting and ENDO presents their Cancer treatment that is noninvasive with 85% cure rate. Easily considered more cost effective than invasive tx with excellent outcomes. Should you approve it and encourage doctors nationwide to use the ENDO procedure? Medicare basis decisions on SAVINGS combined with Treatement OUTCOMES. Regards, S.W.